Charles Schwab’s VolitionRx Ltd VNRX Stock Holding History

Charles Schwab’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-774	Closed	-$9.37K	–	3604
2024 Q2	$9.37K	Buy	774 +5	+0.7%	+$73	﹤0.01%	3616
2024 Q1	$11.6K	Hold	769	–	–	﹤0.01%	3458
2023 Q4	$11K	Hold	769	–	–	﹤0.01%	3523
2023 Q3	$10.6K	Hold	769	–	–	﹤0.01%	3561
2023 Q2	$21.4K	Hold	769	–	–	﹤0.01%	3551
2023 Q1	$29.4K	Hold	769	–	–	﹤0.01%	3450
2022 Q4	$37.4K	Hold	769	–	–	﹤0.01%	3416
2022 Q3	$21K	Hold	769	–	–	﹤0.01%	3476
2022 Q2	$32K	Hold	769	–	–	﹤0.01%	3460
2022 Q1	$47K	Hold	769	–	–	﹤0.01%	3536
2021 Q4	$49K	Hold	769	–	–	﹤0.01%	3516
2021 Q3	$48K	Hold	769	–	–	﹤0.01%	3457
2021 Q2	$51K	Sell	769 -3,248	-81%	-$220K	﹤0.01%	3366
2021 Q1	$304K	Buy	4,017 +409	+11%	+$35.1K	﹤0.01%	3239
2020 Q4	$281K	Hold	3,608	–	–	﹤0.01%	3182
2020 Q3	$232K	Buy	3,608 +310	+9%	+$21.1K	﹤0.01%	3134
2020 Q2	$257K	Buy	3,298 +2,529	+329%	+$183K	﹤0.01%	3111
2020 Q1	$48K	Hold	769	–	–	﹤0.01%	3162
2019 Q4	$73K	Hold	769	–	–	﹤0.01%	3113
2019 Q3	$87K	Hold	769	–	–	﹤0.01%	3099
2019 Q2	$49K	Hold	769	–	–	﹤0.01%	3148
2019 Q1	$50K	Buy	+769	New	+$42.9K	﹤0.01%	3128

Other funds holding VNRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Charles Schwab's VNRX Position: Q3 2024 in Review

Charles Schwab sold out of VolitionRx Ltd (VNRX) in Q3 2024, closing a stake of 774 shares — an estimated $9.37K sold.

Charles Schwab first reported a position in VNRX in Q1 2019 and held it in 22 quarters. The position peaked at $304K in Q1 2021. 22 funds tracked by Wall St. Rank hold VNRX as of Q3 2024.

Charles Schwab reported no remaining VolitionRx Ltd position as of Q3 2024 after selling out during the quarter.
Charles Schwab sold 774 VolitionRx Ltd shares in Q3 2024, an estimated $9.37K.
Charles Schwab first reported a position in VolitionRx Ltd in Q1 2019 and held it in 22 quarters.
Charles Schwab's VolitionRx Ltd position peaked at $304K in Q1 2021.
22 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.